Scientific Program
Print

Thursday, November 7, 2013
08:00- 21:00
Registration
09:00-17:00
Pre-Congress Workshop #1 (Optional):
OVARIAN TISSUE VITRIFICATION AND SLOW FREEZING
09:00-17:00
Pre-Congress Workshop #2 (Optional):
OOCYTE AND EMBRYO VITRIFICATION-THE CRYOTOP-SC
09:00-18:30
Parcialmente financiado por Roche
Acreditación por GEICAM, GEICO, SEOM Y SEHH
19:00 – 19:45
ISFP Members Assembly
20:00 – 21:00
Get together Cocktail
Friday, November 8, 2013
07:30 – 18:45 Registration
08:30 – 09:00
Opening Lecture - Current methods of fertility preservation
Chairpersons: Pedro N. Barri, SPAIN
  Antonio Pellicer, SPAIN

Current methods of fertility preservation
Jacques Donnez, BELGIUM
 09:00 – 11:00
Session 1: Cancer treatment and damage to the genital tract
Chairpersons: Samuel S. Kim, USA
  Federico Perez Milan, SPAIN
09:0009:30
Mechanisms of chemotherapy-induced loss of follicles
Norah Spears, UK
09:3010:00
Cancer induced changes in the testis and spermatozoa
Richard Anderson, UK
10:0010:30
Which young female patients with cancer may benefit from fertility preservation
Hamish Wallace, UK
10:3011:00
Spontaneous recovery of fertility and ovarian function
Kirsten T. Schmidt, DENMARK
11:00 – 11:30
Coffee Break & Poster Viewing
 11:30 – 13:30
Session 2: Fertility sparing strategies in Cancer
Chairpersons: Jacques Donnez, BELGIUM
  Gorka Barrenetxea , SPAIN
11:3012:00
Cervical cancer and preservation of fertility
Michel Roy, CANADA
12:0012:30
Borderline ovarian cancer
Philippe Morice, FRANCE
12:3013:00
Endometrial cancer
Pedro N. Barri, SPAIN
13:0013:30
Medical protection of gonadal damage
Dror Meirow, ISRAEL
13:30 – 14:30
Lunch Break
 14:30 – 16:30

Session 3: Advances in ovarian cortex transplantation
Chairpersons: Dror Meirow, ISRAEL
  Cesar Diaz, SPAIN
14:3015:00
Surgical techniques in tissue transplantation for fertility preservation
Tommaso Falcone, USA
15:0015:30
In vivo post-grafting recovery of folliculogenesis and ovulation
Sherman Silber, USA
15:3016:00
Use of frozen/thawed ovarian tissue for hormone replacement
Claus Y. Andersen, DENMARK
16:0016:30
Risk of transplantation of malignant cells in fertility preservation
Marie-Madeleine Dolmans, BELGIUM
16:30 – 17:00
Coffee Break & Poster Viewing
 17:00 – 19:00
Session 4: Other clinical considerations in fertility preservation
Chairpersons: Claus Y. Andersen, DENMARK
  Ventura Coroleu , SPAIN
17:0017:30
Natural cycle IVM/IVF
Ri Cheng Chian, CANADA
17:3018:00
Ovarian stimulation in cancer patients
Kenny Rodriguez-Wallberg, Sweden
18:0018:30
Fertility preservation in male patients
Herman Tournaye, BELGIUM
18:3019:00
Optimizing patient access to fertility preservation
Jane Ruman, USA
   
17:00 – 18:00
KOREAN PANEL DISCUSSION: HOW TO IMPROVE ART SUCCESS RATE
 
Individualization of COH protocols and drug use
K.C. Kim & W.D. Lee
Management of recurrent early pregnancy loss
C.S. Suh & K.M. Yang
Strategies to reducing embryo transfer number
M.S. Kim & D.J. Chung
Saturday, November 9, 2013
08:00 – 19:00 Registration
 08:30 – 10:30
Session 5: Fertility preservation in vitro
Chairpersons: Marie-Madeleine Dolmans, BELGIUM
  J. Garcia Velasco, SPAIN
08:3008:50
In vitro follicular culture
Evelyn E. Telfer, UK
08:5009:10
The role of in vitro maturation of oocytes
Helen Picton, UK
09:1009:30
Cryopreservation of isolated human preantral follicles for fertility
preservation: a new option
Stine Gry Kristensen, DENMARK
09:3009:50
Slow freezing vs vitrification of ovarian tissue
Outi Hovatta, SWEDEN
09:50 10:10
Activation of dormant ovarian follicles
Kate Hardy, UK
10:10 - 10:30 Q&A
10:30 – 11:00
Coffee Break & Poster Viewing
 11:00 – 13:00
Session 6: Methods of tissue cryopreservation
Chairpersons: Hamish Wallace, UK
  Edurne Novella, SPAIN
11:0011:30
Is there a place for antileukemic in-vitro treatment of ovarian cortex prior to transplantation
Cesar Diaz, SPAIN
11:3012:00
Does oocyte integrity matter with cryopreservation of ovarian tissue?
Samuel S. Kim, USA
12:0012:30
Oocyte vitrification for fertility preservation: Has it come to age?
Ana Cobo, SPAIN
12:3013:00
New strategies in fertility preservation: freeze/dry in vitro perfusion
Pasquale Patrizio, USA
 13:00 – 14:00
Session 7: The future of fertility preservation
Chairpersons: Pedro N. Barri, SPAIN
  Antonio Pellicer, SPAIN
13:0013:30
Science fiction or reality? Producing gametes from stem cells and somatic cells
Gerald Schatten, USA
13:3014:00
Uterine transplantation
Mats Brannstrom, SWEDEN
14:00 – 14:30
Lunch Break
14:30 – 18:45
Free Communication Sessions (parallel sessions)
Hall A
14:30 - 16:15
Clinical Experience 1
Chairpersons: Pasquale Patrizio, USA & Ventura Coroleu , SPAIN
14:30 – 14:45
MINIMAL RESIDUAL DISEASE DETECTION IN OVARIAN CORTEX FROM LEUKEMIA PATIENTS BY EIGHT-COLOR FLOW CYTOMETRY
C. Amiot1,2,3, T. Zver1,2, M. Alvergnas-Vieille1,3, F. Garnache-Ottoui1,2,4, C. Roux
1,2,3
1.
INSERM UMR1098, 1 Bd A Fleming, F-25020 Besançon Cedex, France
2.
Université de Franche-Comté, SFR FED4234, F-25000 Besançon Cedex, France
3.
CHU Besançon, Biologie de la reproduction, CIC-BT506, F-25030 Besançon Cedex, France
4. EFS Bourgogne Franche-Comté, F-25020 Besançon cedex, France
14:45 – 15:00
FERTILITY PRESERVATION PROGRAMME IN YOUNG GIRLS WITH CANCER
M. Andres
1, E. Novella-Maestre2, A. Marco1, S. Garcia-Williams1, JM Rubio2, A. Verdeguer1, A. Pellicer2
1Pediatric Oncology, Hospital Universitario y Politécnico La Fe, Spain
2Fertility Department, Hospital Universitario y Politécnico La Fe, Spain
15:00 – 15:15
THE IMPACT OF THE ADDITION OF TAXANE TO AC REGIMEN ON OVARIAN FUNCTION IN BREAST CANCER PATIENTS: A META-ANALYSIS OF FIVE RANDOMIZED STUDIES
B. Ata2, O. Oktem1,3, Y. Guzel3, S. Aksoy3, B. Urman1,3
1Obstetrics and Gynecology, Koc University School of Medicine, Turkey
2Obstetrics and Gynecology, Uludag University, Turkey
3Women's Health Center Assisted Reproduction Unit, American Hospital, Turkey
15:15 – 15:30
TRIPTORELIN TO PREVENT CHEMOTHERAPY-INDUCED OVARIAN FAILURE IN LYMPHOMA PATIENTS: A PROSPECTIVE RANDOMIZED STUDY
I. Demeestere1, P. Brice2, F.A. Peccatori3, A. Kentos4, I. Gaillard5, P. Zachee6, O. Casasnovas7, E. Van Den Neste8, J. Dechene1, V. De Maertelaere9, D. Bron10, Y. Englert
1
1.
Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium
2.
Haematological Department, St Louis Hospital, APHP, Paris, France
3.
Haematological Department, Istituto Europeo di Oncologia, Milano, Italy
4.
Haematological Department, Erasme Hospital, Brussels, Belgium
5.
Haematological Department, Hôpital Henri Mondor, Paris, France
6.
Haematological Department, Algemeen Ziekenhuis Stuivenberg, Antwerpen, Belgium
7.
Haematological Department, CHU de Dijon, Dijon, France
8.
Haematological Department, Cliniques universitaires UCL Saint-Luc, Brussels
9.
IRIBHM & Biostatistics and Medical Informatics Department, Université Libre de Bruxelles (ULB), Belgium
10. Haematological Department, J. Bordet Institute, Brussels, Belgium
15:30 – 15:45
EFFECTS OF ANTI-MÜLLERIAN HORMONE SUPPLEMENTATION ON CRYOPRESERVED AND TRANSPLANTED OVARIAN TISSUES
H.S. Kong1,2, J. Lee1,2, E.J. Kim1, H.Y. Youm1,2, J.R. Lee1,2, C.S. Suh1,2, S.H. Kim2
1Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, South Korea
2Department of Obstetrics and Gynecology, Seoul National University College of Medicine, South Korea
15:45 – 16:00
PATIENTS WİTH ENDOMETRIAL CARCINOMA SEEKING FOR FERTILITY
H.A. Parlakgumus1, E.B. Kilicdag1, E. Simsek1, B. Haydardedeoglu1, T. Cok1, P.C. Aytac1, T. Bagis2, S. Erkanli
2
1.
Baskent University, Ankara, Turkey
2. Acbadem University, Istanbul
16:00 – 16:15
EXPERIENCE ON FERTILITY PRESERVATION AT HOSPITAL CLÍNICO SAN CARLOS
C.S. Piñel Pérez1,2, S. Ortega Ricondo1,2, M. Calvo Urrutia1,2, P. Gasca Escorial1,2, S. Rafael Fernández1,3, M. Vidaurreta Lázaro1,3, M.L. Maestro de las Casas1,3, M.A. Herráiz Martínez1,2
1Unidad de Reproducción Asistida, Hospital Clínico San Carlos, Spain
2Servicio de Obstetricia y Ginecología, Hospital Clínico San Carlos, Spain
3Servicio de Análisis Clínicos, Hospital Clínico San Carlos, Spain
16:15 – 16:45
Coffee Break & Poster Viewing
16:45 - 18:45
Experimental Procedures
Chairpersons: Ri Cheng Chian, CANADA & Edurne Novella, SPAIN
16:45 – 17:00 FIRST TRANSPLANTATION OF A BIODEGRADABLE ARTIFICIAL OVARY CONTAINING ISOLATED MURINE FOLLICLES: HOPE FOR CLINICAL APPLICATION
C. A. Amorim
1, J. Vanacker1, V. Luyckx1, A. V. Langendonckt1, J. Donnez2, M.M. Dolmans1,3
1Pôle de Recherche en Gynécologie, Université Catholique de Louvain, Belgium
2Gynecology, Society for Research into Infertility, Belgium
3Gynecology, Cliniques Universitaires Saint-Luc, Belgium
17:00 – 17:15
EFFECT OF EARLIER CANCER TREATMENT ON THE MATURATION CAPACITY OF FOLLICLES IN THAWED OVARIAN CORTICAL TISSUE
B. Asadi1,2, M. Sheikhi3, I.C. Oskam4, M. Nurmio5, H. Tinkanen6, T.G. Tanbo1,2, O. Hovatta3, K. Jahnukainen3,7,8
1. Oslo University Hospital-Rikshospitalet, Oslo, Norway
2. University of Oslo, Oslo, Norway
3. Karolinska University Hospital, Huddinge, Stockholm, Sweden
4. Bio Kapital, Hamar, Norway
5. University of Turku, Turku, Finland
6. Tampere University Central Hospital, Tampere, Finland
7. Helsinki University Central Hospital, Helsinki, Finland
8. University of Helsinki, Helsinki, Finland
17:15 – 17:30 PROTECTIVE EFFECTS OF POLYETHYLENEGLYCOL-ADSORBED–SUPEROXIDE DISMUTASE (PEG-SOD) ON OVARIAN TISSUE TRANSPLANTATION
EJ. Kim1,2, JW. Lee1,2, HS. Kong1,2, HW. Youm1,2, JR. Lee1,2, CS. Suh1,2, SH. Kim2
1Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, South Korea
2Department of Obstetrics and Gynecology, Seoul National University College of Medicine, South Korea
17:30 – 17:45 NEUTRAL RED AS VIABILITY MARKER FOR ISOLATED, BOVINE PRE-ANTRAL OVARIAN FOLLICLES: OPTIMAL CONCENTRATION AND INCUBATION TIME
A. Langbeen
, E. Jorssen, N. Granata, E. Fransen, J. Leroy, P. Bols
Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Belgium
17:45 – 18:00 ANTIMETABOLITE CANCER DRUG GEMCITABINE IMPACTS PREANTRAL AND ANTRAL FOLLICLE COHORTS IN THE OVARY
O. OKTEM, A. Yuksel, F. Unal, Y. Guzel, M. Polat, S. Aksoy, B. Urman
Obstetrics and Gynecology, Koc University School of Medicine, Turkey
18:15 – 18:30 MATURATION OF PRIMORDIAL FOLLICLES CO-CULTURED WITH STROMAL CELLS IN ALGINATE SCAFFOLDS
M. Shachar (Goldenberg)
1, Y. Kaminer-Israeli1,2, A. Kedem3, A. Hourvitz3, S. Cohen2
1Department of Chemical Engineering, Sami Shamoon College of Engineering, Israel
2The Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Israel
3IVF Unit and Reproduction Lab, Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel
18:30 – 18:45
OVARIAN TISSUE VITRIFICATION OF YOUNG CANCER PATIENTS FOR FERTILITYPRESERVATION IN JAPAN. "THE FISRT LIVEBIRTH FROM VITRIFIED OVARIAN TISSUES
S. Takae
1, C Nishijima1, N Yoshioka1, Y Sugishita1, Y Horage1, M Ishiyama1, T Haino1, K Kawamura1, B Ishizuka2, N Suzuki1
1Obstetrics and Gynecology, St. Marianna University School of Medicine, Japan
2Advanced Reproductive Medicine, St. Marianna University School of Medicine, Japan
In parallel
HALL B
14:30 – 16:15 Clinical Experience 2
Chairpersons: Marie-Madeleine Dolmans, BELGIUM & Cesar Diaz, SPAIN
14:30 – 14:45
A COMPARATIVE STUDY ON ICSI OUTCOMES USING CRYOPRESERVED SPERM FROM MALE ONCOFERTILITY PRESERVATION CASES AND FROM NON-CANCEROUS CASES OF INFERTILITY
A. Garcia, MB. Herrero, WY. Son, H. Hananel, T. Tulandi, P. Chan
Department of Obstetrics and Gynecology. Department of Urology, McGill University Health Centre Reproductive Centre, Canada
14:45 – 15:00 EFFECTIVENESS OF A DECISION AID ABOUT FERTILITY PRESERVATION FOR BREAST CANCER PATIENTS
M. Garvelink1
, M. ter Kuile1, L. Louwé1, C. Hilders2, A. Stiggelbout3
1Department of Gynecology, Leiden University Medical Center, The Netherlands
2Department of Gynecology, Reinier de Graaf Hospital, The Netherlands
3Department of Medical Decision Making, Leiden University Medical Center, The Netherlands
15:00 – 15:15
OVARIAN RESERVE AFTER COMPLEX TREATMENT FOR POST CRANIAL FOSSA TUMORS IN CHILDHOOD
E. Gubernatorova1, T. Tselovalnikova1, M. Pavlova1, N. Mazerkina1, T. Kaznacheeva2, E. Kotlyrovskaya1
1Endocrinology, I.M. Sechenov First Moscow State Medical University, Russia
2Reproductive Medicine and Surgery, Moscow State Medical Dental University, Russia
15:15 – 15:30 DIMINISHED OVARIAN RESERVE IN WOMEN WITH ENDOMETRIOMA: CONCERNS FOR FERTILITY PRESERVATION IN WOMEN WITH ENDOMETRIOSIS
M. Kitajima1,2
, A. VanLangendonkt2, M.M. Dolmans2, J. Donnez3, H. Masuzaki1
1Department of Obstetrics and Gynecology, Nagasaki University, Japan
2Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Belgium
3Infertility Research Unit, SRI, Belgium
15:30 – 15:45
SUCCESSFUL PREGNANCY CONFIRMS THE ROLE OF HETEROTOPIC OVARIAN GRAFTING
G. Rozen
1,2, F. Agresta1,2, L. Hale1,2, D. Gook1,2, A. Sampson3, C. Stern1,2
1Reproductive Biology, Melbourne IVF, Australia
2Reproductive Services Unit, Royal Women's Hospital, Australia
3Obstetrics and Gynaecology Ultrasound Department, Royal Women's Hospital, Australia
15:45 – 16:00
16:00 – 16:15
A SAFE TECHNIQUE TO ISOLATE PRIMORDIAL FOLLCILES IN PATIENTS WITH LEUKEMIA
M. Soares
1, K. Sahrari1, P. Saussoy2, A.V. Langendonckt1, C.A. Amorim1, V. Luyckx1, J. Donnez3, M.M. Dolmans1,4
1Pôle de Recherche en Gynécologie, Université catholique de Louvain, Belgium
2Department of Clinical Biology, Université catholique de Louvain, Belgium
3Gynecology, Society for Research into Infertility, Belgium
4Gynecology, Cliniques Universitaires Saint-Luc, Belgium
16:15 – 16:45
Coffee Break & Poster Viewing
16:45 – 18:30 Vitrification – Motivation
Chairpersons: Dror Meirow, ISRAEL & Sonia Herráiz, SPAIN
16:45 – 17:00
COMPARISON OF FOLLICLE QUALITY IN HUMAN OVARÍAN TISSUE AFTER CONVENTIONAL SLOW FREEZING (SF) OR VITRIFICATION (V) USING OVARIES REMOVED FROM FEMALE-TO-MALE TRANSSEXUALS PATIENTS (FTMS)
A. Borras Capo1, F. Fàbregues Gasol1,2, J.M. Calafell Pozo1, M.D. Manau Trullas1,2, A. Valera1,2, J. Ordi1,2, J. Balasch Cortina1,2
1. Hospital Clínic de Barcelona, Barcelona, Spain
2. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
17:00 – 17:15
CONTROLLED OVARIAN HYPERSTIMULATION(COH) FOR FERTILITY PRESERVATIONIN 48 YOUNG CANCER PATIENTS:A PROSPECTIVE COMPARATIVE STUDY WITH TIME AND AGE-MATCHED HEALTHY COINTROLS
C. Decanter
1, L. Keller2, J. Sigala2, J. Salleron3, P. Devos3, C. Ballot, M. Peigne1, D. Dewailly1, V. Mitchell2, B. Leroy-Martin2
1reproductive medicine and fertility preservation center, hopital Jeanne de Flandre, Lille University Hospital, France
2reproductive Biology Institute, Hopital jeanne de Flandre, Lille University Hospital, France
3department of biostatistic, Lille university Hospital, France
17:15 – 17:30 OVARIAN STIMULATION FOR FERTILITY PRESERVATION DOES NOT PERFORM WORSE NOR DELAY ONCOLOGIC TREATMENT IN BREAST CANCER PATIENTS
M. Devesa
, B. Coroleu, R. Fábregas, S. Baulies, C. González, I. Rodríguez, P.N. Barri, P.N. Barri
Obstetrics, Gynecology and Reproductive Medicine, Hospital Universitari Quirón-Dexeus, Spain
17:30 – 17:45
EFFECTS OF SIMVASTATIN TREATMENT ON VITRIFIED-WARMED MOUSE OVARIAN TISSUE TRANSPLANTATION
J. Lee1,2,
H.Y Youm1,2, J.R Lee1,2, C.S Suh1,2, S.H Kim2
1Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, South Korea
2Department of Obstetrics and Gynecology, Seoul National University College of Medicine, South Korea
17:45 – 18:00
HAVING CHILDREN IN SURVIVORSHIP: ARE WOMEN CANCER PATIENTS POSITIVELY MOTIVATED TO PRESERVE THEIR FERTILITY?
C. Melo1,2, T. Almeida-Santos3,4, M.C. Canavarro1,2
1. Faculty of Psychology and Educational Sciences, University of Coimbra, Portugal
2. Unity of Psychological Intervention, Maternity Dr. Daniel de Matos, Coimbra Hospital and University Centre, Portugal
3. Faculty of Medicine, University of Coimbra, Portugal
4. Centre for Fertility Preservation, Human Reproduction Service, Coimbra Hospital and University Centre, Portugal
18:00 – 18:15 THE PORTRAYAL OF HEALTHY WOMEN REQUESTING OOCYTE CRYOPRESERVATION
H. Mertes

Bioethics Institute Ghent (BIG), Ghent University, Belgium
18:15 – 18:30 LIVE BIRTH WIH A CRYOPRESERVED UNFERTILIZED OOCYTE RETRIEVED BEFORE BONE MARROW TRANSPLANTATION
Y. Nakamura
, Y Fujino, K Koike, Y Koma, Y Koma, E Wakimoto, A Tsuchitani
Reproduction, Fujino ladies clinic, Japan